Relmada Therapeutics Inc. (RLMD)
0.75
0.06 (8.70%)
At close: Apr 24, 2025, 2:55 PM
Relmada Therapeutics Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for RLMD stock have an median target of 1, with a low estimate of 1 and a high estimate of 2. The median target predicts an increase of 33.33% from the current stock price of 0.75.
Latest Analyst Insight Report
According to 4 stock analyst, the rating for Relmada Therapeutics Inc. is "Hold". This means that the analyst believes this stock is likely to lead to similar returns than market as a whole.
Financial Forecast this Year
Revenue This Year
2.46M
from 0
Increased by -%
Revenue Next Year
10M
from 2.46M
Increased by 306.7%
EPS This Year
-0.95
from 0
Increased by -%
EPS Next Year
-0.8
from -0.95
Increased by 15.8%